Results 61 to 70 of about 40,797 (259)

Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

Journal of Thrombosis and Haemostasis, 2021
Some local protocols suggest using intermediate or therapeutic doses of anticoagulants for thromboprophylaxis in hospitalized patients with coronavirus disease 2019 (COVID‐19).
P. Demelo-Rodríguez, A. Farfán-Sedano, J. Pedrajas, P. Llamas, P. Sigüenza, M. J. Jaras, Manuel Quintana-Díaz, C. Fernández-Capitán, B. Bikdeli, D. Jiménez, M. Monreal   +10 more
semanticscholar   +1 more source

Thromboprophylaxis after bariatric surgery

BLOOD RESEARCH, 2020
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a known cause of morbidity and mortality after bariatric surgery. However, the data concerning appropriate thromboprophylaxis after bariatric surgery is uncertain.
Almarshad, Feras M., Almegren, Mosaad, Alshuaibi, Turki, Alobaodi, Nadiah, Almutawa, Ali, Basunbl, Hajer, AlGahtani, Farjah, Al Rawahi, Bader   +7 more
openaire   +3 more sources

Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.

Cochrane Database of Systematic Reviews, 2019
BACKGROUND This an update of the review first published in 2009.Major abdominal and pelvic surgery carries a high risk of venous thromboembolism (VTE). The efficacy of thromboprophylaxis with low molecular weight heparin (LMWH) administered during the in-
Seth I. Felder, M. Rasmussen, Ray S. King, B. Sklow, Mary R. Kwaan, R. Madoff, C. Jensen   +6 more
semanticscholar   +1 more source

Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis

British Journal of Haematology, 2021
Incidence of venous thromboembolism (VTE) varies across different regimens in newly diagnosed multiple myeloma (NDMM) patients. Limited data exist on the use of direct oral anticoagulants as thromboprophylaxis in the setting of haematologic malignancies,
Katrina Piedra, Tim J. Peterson, C. Tan, Jennifer S. Orozco, M. Hultcrantz, H. Hassoun, S. Mailankody, A. Lesokhin, U. Shah, Sydney X Lu, D. Patel, Andriy Derkach, Cy R. Wilkins, N. Korde   +13 more
semanticscholar   +1 more source

Obstetric Thromboprophylaxis: The Swedish Guidelines

Advances in Hematology, 2011
Obstetric thromboprophylaxis is difficult. Since 10 years Swedish obstetricians have used a combined risk estimation model and recommendations concerning to whom, at what dose, when, and for how long thromboprophylaxis is to be administrated based on a ...
Pelle G. Lindqvist, Margareta Hellgren
doaj   +1 more source

Normal pregnancy is associated with an increase in thrombin generation from the very early stages of the first trimester [PDF]

, 2017
Background: Pregnancy is a hypercoagulable state associated with an increased risk of venous thrombosis, which begins during the first trimester, but the exact time of onset is unknown.
Bagot, C.N., Freeman, D.J., Jordan, F., Leishman, E., Onyiaodike, C.C.   +4 more
core   +1 more source

High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis

Internal and Emergency Medicine, 2022
Hospitalized COVID-19 patients are at high risk of venous thromboembolism (VTE). Standard doses of anticoagulant prophylaxis may not be sufficiently effective for the prevention of VTE.
E. Valeriani, Angelo Porfidia, W. Ageno, S. Spoto, R. Pola, M. Di Nisio   +5 more
semanticscholar   +1 more source

The Use of venous thromboembolism prophylaxis in relatioN to patiEnt risk profilINg (TUNE IN) Wave 3 study

South African Medical Journal
Background. Thromboprophylaxis significantly reduces the risk of venous thromboembolism (VTE) in hospitalised medical and surgical patients. Nonetheless, the implementation of thromboprophylaxis in South Africa (SA) and worldwide is low.
J Bassett, E Schapkaitz, B Jacobson
doaj   +1 more source

How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?

Clinical and Applied Thrombosis/Hemostasis, 2022
Low-molecular-weight heparin (LMWH) is suggested for thromboprophylaxis in pregnant women with previous venous thromboembolism (VTE ) . Anyway, there is only limited amount of studies evaluating the effect of LMWH on hemostatic parameters during ...
Lucia Stanciakova MD, PhD, Miroslava Dobrotova MD, PhD, Pavol Holly MD, PhD, Jana Zolkova MSc, PhD, Lubica Vadelova MSc, PhD, Ingrid Skornova MA, PhD, Jela Ivankova MSc, Matej Samos MD, PhD, Tomas Bolek MD, PhD, Marian Grendar MSc, PhD, Jan Danko MD, PhD, Peter Kubisz MD, DSc, Jan Stasko MD, PhD   +12 more
doaj   +1 more source

Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study

Journal of Clinical Medicine, 2022
Sickle cell disease (SCD) induces a chronic prothrombotic state. Central venous access devices (CVADs) are commonly used for chronic transfusions and iron chelation in this population. CVADs are an additional venous thromboembolism (VTE) risk factor. The
S. Forté, Gonzalo De Luna, J. Abdulrehman, Nafanta Fadiga, Olivia Pestrin, Anne-Laure Pham Hung d'Alexandry d'Orengiani, J. Aneke, H. Guillet, Dalton Budhram, A. Habibi, R. Ward, P. Bartolucci, K. Kuo   +12 more
semanticscholar   +1 more source